Crom Carmichael Discusses the Bureaucratic Attempt at Managing the Distribution of Monoclonal Antibodies Source

Crom Carmichael Discusses the Bureaucratic Attempt at Managing the Distribution of Monoclonal Antibodies Source

 

Live from Music Row Wednesday morning on The Tennessee Star Report with Michael Patrick Leahy – broadcast on Nashville’s Talk Radio 98.3 and 1510 WLAC weekdays from 5:00 a.m. to 8:00 a.m. – host Leahy welcomed the original all-star panelist Crom Carmichael in studio to weigh in on the Biden administration’s desperate attempt to gain control at the source of the monoclonal antibody COVID-19 and its distribution.

Leahy: In the studio, the original all-star panelist Crom Carmichael. Crom, during the break, you were telling me about this crazy press conference in which White House staffers, in essence, shut down and insulted the prime minister of the United Kingdom.

Carmichael: No, it wasn’t that. The aids, what they did was they shouted down when the press started asking questions of Biden about the southern border, the White House aides in the room started making so much noise that you couldn’t hear the answer.

And essentially shut down the questioning. I want to get back to what you were talking about. And I want to try to tie this into a whole lot of other things because to me, they are all related. You and I can agree that the exit from Afghanistan was a fiasco?

Leahy: Debacle.

Carmichael: We can agree that the control of the southern border is just terrible.

Leahy: A violation of American immigration law by the Biden maladministration. There’s a story here that the U.S. pledged to send vaccines to others around the world. It apparently is also just a complete disaster for logistical reasons.

So all of the major things like policy initiatives or things that the administration is supposed to be doing, they’ve all been executed terribly. Just terribly. We could say this is just an example of just gross incompetence.

Leahy: That’s one thing we could say.

Carmichael: We could. What would be the worst thing you could say?

Leahy: It’s intentional.

Carmichael: Yeah, that it’s intentional.

Leahy: That’s the most likely.

Carmichael: And I believe that all of this is intentional.

Leahy: I agree, too.

Carmichael: Let’s go back to when COVID broke and hydroxychloroquine was suggested that it could help people if they took it either as a prophylactic or if they took it immediately upon a diagnosis.

And Fauci and the entire federal government on the health care side shouted that down and called people names and really just shut down the distribution of a generic product. Just shut it down.

Leahy: Shut it down.

Carmichael: Now then later we find out that hydroxychloroquine actually did help.

Leahy: In certain circumstances.

Carmichael: And there’s no evidence that it ever hurt. On balance, it was helpful.

Leahy: But depending upon your circumstances.

Carmichael: And not how your doctors provided it. I’m saying on balance.

Leahy: On balance. I’m agreeing with you. It was helpful.

Carmichael: What I’m saying is that now you have this monoclonal. I can’t pronounce it.

Leahy: Monoclonal antibody.

Carmichael: Now it looks as if it works. The evidence is 70 percent of the time. It helps. So what is the Biden administration doing? They are trying to gain control of the source.

Leahy: Magic statement there Crom. That’s what’s happening.

Carmichael: And they are not just trying. They’re gaining control of the distribution. That’s why I was so important in the earlier one when I said this is how pharmaceuticals are distributed. This is the logistics. So you have the Biden administration.

Leahy: That is another way. It’s a way when the marketplace such as this is working and you have a pharmaceutical like this, the distributor who’s been vetted and approved.

Carmichael: And knows how to handle the drug.

Leahy: How to handle the drug and how to move it through the supply chain to get that it can be delivered over to patients.

Carmichael: Quickly. Yes.

Leahy: The people who know what they’re doing.

Carmichael: Yes. And Biden is saying we’re going to abandon the system that works, and we’re going to replace it with a bureaucratic system that manages distribution.

Leahy: Which never works.

Carmichael: Which won’t work because the people who are now in charge have never done it right. Let’s look at an article in The Wall Street Journal. Headline.

U.S. Pledged to Vaccinate Poor Countries Stumbles Amid Logistical Challenges. And this article goes on to point out that there are so many different things about the handling of pharmaceuticals to address COVID that require special handling that the Biden administration people are clueless.

Leahy: Well, they’re political hacks. And they don’t know anything about the supply chain or managing medical supplies. They’re hacks.

Carmichael: Right. But yet they are the ones who are in charge. They now want to be in charge, and they’re about to be in charge of the distribution of a very important pharmaceutical throughout the U.S. market.

So here’s my question Michael. And I’ve raised this over and over again. Let’s even look at it from the standpoint of Tennessee.

If somebody who would have lived dies because of a bureaucratic decision to specifically withhold the drugs from that person is the bureaucrat that did it as liable as a police officer who shoots somebody while they are on duty?

Leahy: Let me answer that question. I think it’s a great question. I think the answer is that the way things work right now, there’s no liability. Would you agree with that?

Carmichael: I asked the question because I literally don’t know. What I’m saying is is if the Biden administration takes control of the distribution of pharmaceuticals, and then it is found that they are specifically denying pharmaceuticals to red states, let’s say or they’re giving as much as New York wants and as much as California wants but denying the drug to Florida and Tennessee and Alabama and Texas. Let’s just say that it’s doing that.

Leahy: And it looks like it.

Carmichael: But you find absolute documentation. You can prove it.

Leahy: And you can prove it.

Carmichael: My question is, can any of those people be held criminally liable?

Leahy: Let’s just say a 66-year-old male who’s got the vaccine tests positive for COVID-19 goes in and asks his doctor to get the monoclonal antibody treatment is denied because of the Biden administration policy.

And then if that person then becomes sick and dies, what does his family do? What recourse do they have?

Carmichael: Right. That’s the question.

Listen to the full second hour here:

– – –

Tune in weekdays from 5:00 – 8:00 a.m. to the Tennessee Star Report with Michael Patrick Leahy on Talk Radio 98.3 FM WLAC 1510. Listen online at iHeart Radio.

 

 

 

 

 

 

 

 

 

 

 

 

 

Crom Carmichael Weighs in on Tennessee Department of Health’s Decision to Not Offer Monoclonal Antibodies to Fully Vaccinated People

Crom Carmichael Weighs in on Tennessee Department of Health’s Decision to Not Offer Monoclonal Antibodies to Fully Vaccinated People

 

Live from Music Row Wednesday morning on The Tennessee Star Report with Michael Patrick Leahy – broadcast on Nashville’s Talk Radio 98.3 and 1510 WLAC weekdays from 5:00 a.m. to 8:00 a.m. – host Leahy welcomed the original all-star panelist Crom Carmichael to the studio to discuss the Tennessee Department of Health’s announcement that fully vaccinated COVID-19 persons will not receive the monoclonal antibody treatment.

Leahy: We are joined in studio by the original all-star panelist Crom Carmichael. Crom, good morning.

Carmichael: Good morning, Michael.

Leahy: I’m going to need your help, Crom, unraveling this mystery. And it makes no sense to me as most of the things going on with the Biden administration.

But this is in particular what’s going on with the Tennessee Department of Health as well. So, are you ready to put on your mystery-solving hat?

Carmichael: I’m listening.

Leahy: You’re listening?

Carmichael: Yes.

Leahy: So you may recall that I’ve talked a little bit about my personal game plan for COVID-19.

Carmichael: Yes.

Leahy: I do not have COVID-19. I have never had COVID-19. I’ve gotten the Pfizer vaccine. Both shots.

Carmichael: Good for you.

Leahy: But everywhere you look, there are breakthrough cases of COVID-19, right? People have got their shots and they get COVID-19. I’ve told you what my plan is. My plan has been okay.

If I test positive, I will follow the best recommendation of doctors, which is to go immediately and get a monoclonal antibody treatment if my provider would do that.

Carmichael: You have said that yes.

Leahy: Many a time I’ve said that. I don’t know about many of the time.

Carmichael: But you’ve said it.

Leahy: I’ve said it on air.

Carmichael: That’s where I know it’s true.

Leahy: Privately, I said I told everybody that’s my plan, everybody. Because I know you’re waiting to know what my plan is. Why? Because you have to have your plan. So here’s the thing, Crom. Headline.

Our lead story this broke last night and everyone is scratching their head about it. We’re going to have State Representative Scott Cepicky on at 7:30 a.m.

He’s going to help unravel this and get his thoughts on it. Here’s the headline. Tennessee Department of Health says Vaccinated Not Recommended for Monoclonal Antibody Treatment. Now, why is that?

Carmichael: Why do you have to be recommended anyway?

Leahy: Well, that’s a very good question. That’s a very good question. The reason is these are guidelines. On September 3, the National Institute of Health put out guidelines. And in response to these guidelines, Lisa Piercy…

Carmichael: What are the National Institute of Health guidelines?

Leahy: Put out September 3.

Carmichael: Yes, what are they?

Leahy: While there are currently no shortages of these monoclonal antibodies, by the way, on September 3, a week later, Biden announces rationing of them.

And so far, as far as I can tell, Regeneron and Eli Lilly make these items and they’re purchased from them by the federal government. And then they distribute them.

Carmichael: Only? Is that the way it’s always been?

Leahy: I’m trying to figure this out. This is a new treatment just recently approved by the FDA.

Carmichael: It’s never been that way.

Leahy: Actually, in this particular instance, as far as I know, and we have a call into Regeneron. Right now during the break, I called them and I said, we want to know if a private hospital went to you and said, we want to buy some monoclonal antibodies would you sell it to them?

Carmichael: Or if a pharmaceutical distributor.

Leahy: Anybody.

Carmichael: It’s not anybody. The pharmaceutical industry operates in the similar way to the liquor industry.

Leahy: Through distributors.

Carmichael: Through distributors. And you have to have an account set up. You have to be vetted. I’m not trying to defend anything.

Leahy: No, no. This is why you are the original all-star panelist. Knowing these details is very important.

Carmichael: It is a controlled industry, just as alcohol is a controlled industry. And so consequently, you have to have a license.

You have to have a license, for example, to sell alcohol. You can’t just be a retailer and open a store. You have to go through a process and a doctor or a hospital or a pharmaceutical has to have a license in order to issue drugs that are covered by the FDA. In other words, they’re not over the counter.

I’m not trying to defend anybody. I want to explain this. As far as I know, pharmaceutical products are purchased by distributors. And in the case of Walgreens and CVS or the great big ones, they might have a company-owned distributorship.

Leahy: Or some of the larger hospital chains.

Carmichael: Exactly.

Leahy: Let me go with this guideline. It’s called the COVID-19 Treatment Guideline Panel. It’s from the National Institute of Health. We are on September 22nd. This was issued 19 days ago on September third.

While there are currently no shortages of these monoclonal antibodies, logistical constraints or Biden’s administration policies can make it difficult to administer these agents to all eligible patients in situations where it is necessary to triage eligible patients the panel suggests prioritizing the following groups over vaccinated individuals who are expected to have mounted an adequate immune response.

Number one, unvaccinated or incompletely vaccinated individuals who are at high risk of progressing to severe COVID-19 are at a higher priority, the panels suggest. But it does also say vaccinated individuals are not expected to mount an adequate immune response eg immunocompromised individuals. It goes on to say that these are clinical decisions made by the healthcare provider.

But how does the Tennessee Department of Health Commissioner Lisa Piercy interpret these rules? This is their quote from The Epoch Times story via The Tennesseean.

“The emergency use authorization of these monoclonal antibodies is only for people with these conditions, and it has been the same since day one. The new thing is the NIH criteria. What we just read to you was released on September 3. Even if you have those conditions, but you’re vaccinated, you don’t get it now.”

That’s not how I read the NIH guidelines.

It doesn’t say you don’t get it if you’re vaccinated. The guideline says that you’re not on the top priority. It doesn’t mean you don’t and also, it says it is your provider who makes the decision.

That is your health care provider. But nonetheless, Bill Lee’s, Commissioner of Health, is saying, you can. She just said it in this quote. You cannot get monoclonal antibiotic treatment if you’re vaccinated.

Carmichael: Let me ask a back question.

Leahy: I’m listening.

Carmichael: What’s the name of this person?

Leahy: Lisa Piercy. Commissioner of health.

Carmichael: Wasn’t the previous commissioner of health fired?

Leahy: No, she was not the previous commissioner of health. She was like, two layers down. She was in charge of immunization. It was the same type of thing.

It had to do with vaccinations and what the government policy had to do with that lower-level bureaucrat’s interpretation of the mature minor policy as it relates to vaccinating kids without the approval of their parents. A different deal.

Carmichael: But COVID-related.

Leahy: It was COVID related.

Carmichael: What I’m saying is that the other person got fired for trying to micromanage an area of COVID and requiring people to essentially bend the knee to that opinion or whatever it was. And got pressure for that or they got fired.

Leahy: Not exactly. It’s Michelle Fiscus, I think, was her name. There were multiple reasons why she got fired, according to the department of health.

One of them had to do with a bad work environment. The other was she without proper vetting and set forward a state policy that the legal counsel had not approved.

Carmichael: Beurecratic overreach.  Would that be a sufficient description? I’m asking that because what you have told me also appears to be a bureaucratic overreach. We’ll continue this after the break.

Leahy: We’ll see what Representative Scott Cepicky says about that at 7:30. We have so much to talk about here and so little time and so little time. A crazy Biden press conference.

Listen to the second hour here:

– – –

Tune in weekdays from 5:00 – 8:00 a.m. to the Tennessee Star Report with Michael Patrick Leahy on Talk Radio 98.3 FM WLAC 1510. Listen online at iHeart Radio.